John Boyer Inc’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$866K Buy
3,312
+25
+0.8% +$6.41K 0.68% 19
2026
Q2
$827K Buy
3,287
+30
+0.9% +$6.45K 0.72% 22
2026
Q1
$709K Buy
3,257
+23
+0.7% +$5.1K 0.71% 21
2025
Q4
$739K Buy
3,234
+15
+0.5% +$3.42K 0.75% 21
2025
Q3
$745K Buy
+3,219
New +$656K 0.74% 21

Other funds holding ABBV

John Boyer Inc's ABBV Position: Q3 2026 in Review

John Boyer Inc increased its AbbVie (ABBV) stake by 0.76% in Q3 2026, buying an estimated $6.41K and bringing the position to 3,312 shares worth $866K. The position accounts for 0.68% of the portfolio, ranked #19.

John Boyer Inc first reported a position in ABBV in Q3 2025 and has held it in 5 quarters since. 4,275 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • John Boyer Inc held 3,312 shares of AbbVie worth $866K as of Q3 2026.
  • John Boyer Inc bought 25 AbbVie shares in Q3 2026, an estimated $6.41K.
  • AbbVie made up 0.68% of John Boyer Inc's portfolio in Q3 2026, its #19 holding.
  • John Boyer Inc first reported a position in AbbVie in Q3 2025 and has held it in 5 quarters since.
  • 4,275 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on John Boyer Inc's 13F filing for Q3 2026, filed 27 Oct 2026.